We are live on ! Find out more
New York State Common Retirement Fund

New York State Common Retirement Fund Portfolio holdings

AUM $79.3B
1-Year Est. Return 43.63%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$84.1B
AUM Growth
+$5.09B
Cap. Flow
-$1.63B
Cap. Flow %
-1.94%
Top 10 Hldgs %
18.93%
Holding
3,277
New
52
Increased
520
Reduced
1,986
Closed
73

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$159M
2
STI
SunTrust Banks, Inc.
STI
+$56.2M
3
AAPL icon
Apple
AAPL
+$55.2M
4
DE icon
Deere & Co
DE
+$54.1M
5
JPM icon
JPMorgan Chase
JPM
+$48.2M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Financials 15.73%
3 Healthcare 14.42%
4 Consumer Discretionary 10.02%
5 Communication Services 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBUS icon
3076
Cibus
CBUS
$138M
$46K ﹤0.01%
132
ACTG icon
3077
Acacia Research
ACTG
$470M
$45K ﹤0.01%
16,993
-29,707
-64% -$81.4K
RMNI icon
3078
Rimini Street
RMNI
$471M
$45K ﹤0.01%
11,536
SND icon
3079
Smart Sand
SND
$194M
$45K ﹤0.01%
17,900
IDEX
3080
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$45K ﹤0.01%
418
KLDO
3081
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$45K ﹤0.01%
8,900
GCAP
3082
DELISTED
Gain Capital Holdings, Inc.
GCAP
$45K ﹤0.01%
11,300
AXLA
3083
DELISTED
Axcella Health Inc. Common Stock
AXLA
$44K ﹤0.01%
440
EVLO
3084
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$44K ﹤0.01%
540
LNAI
3085
Lunai Bioworks
LNAI
$10.9M
$43K ﹤0.01%
106
LOGC
3086
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$42K ﹤0.01%
5,800
BXRX
3087
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$42K ﹤0.01%
+4
New +$34.1K
MIRM icon
3088
Mirum Pharmaceuticals
MIRM
$6.14B
$40K ﹤0.01%
1,612
-4,300
-73% -$45.8K
MRKR icon
3089
Marker Therapeutics
MRKR
$18.7M
$40K ﹤0.01%
1,400
-1,360
-49% -$49.5K
ACER
3090
DELISTED
Acer Therapeutics Inc
ACER
$39K ﹤0.01%
9,700
USWS
3091
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$39K ﹤0.01%
986
TREC
3092
DELISTED
Trecora Resources
TREC
$39K ﹤0.01%
5,500
-13,900
-72% -$114K
LJPC
3093
DELISTED
La Jolla Pharmaceutical Company
LJPC
$39K ﹤0.01%
10,000
-12,000
-55% -$70.9K
AXAS
3094
DELISTED
Abraxas Petroleum Corp
AXAS
$38K ﹤0.01%
5,390
UNT
3095
DELISTED
UNIT Corporation
UNT
$36K ﹤0.01%
51,400
QUAD icon
3096
Quad
QUAD
$525M
$34K ﹤0.01%
7,300
-23,400
-76% -$146K
TGA
3097
DELISTED
Transglobe Energy Corp
TGA
$34K ﹤0.01%
24,486
GNLN icon
3098
Greenlane Holdings
GNLN
$1.23M
0
VHI icon
3099
Valhi
VHI
$450M
$33K ﹤0.01%
1,450
PRTH icon
3100
Priority Technology Holdings
PRTH
$444M
$31K ﹤0.01%
12,700

Similar funds

New York State Common Retirement Fund's Q4 2019 Portfolio in Review

As of Q4 2019, New York State Common Retirement Fund held 3,277 positions worth $84.1B, up 6.4% from $79B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.8%. New York State Common Retirement Fund opened 52 new positions and exited 73, leaving the 3,277-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • New York State Common Retirement Fund's largest Q4 2019 buy was Canadian National Railway: 160,800 shares worth $14.5M.
  • New York State Common Retirement Fund added most to Bristol-Myers Squibb in Q4 2019, an estimated $86.8M increase.
  • New York State Common Retirement Fund's biggest Q4 2019 reduction was Apple, cutting an estimated $55.2M.
  • New York State Common Retirement Fund fully exited Celgene Corp in Q4 2019, selling an estimated $159M.
  • New York State Common Retirement Fund's ten largest holdings make up 19% of its $84.1B portfolio in Q4 2019.
  • New York State Common Retirement Fund opened 52 new positions and closed 73 in Q4 2019.
  • New York State Common Retirement Fund's portfolio value rose 6.4% quarter-over-quarter to $84.1B.

Based on New York State Common Retirement Fund's 13F filing for Q4 2019, filed 5 Feb 2020.